S. Haenisch

发表

Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity.

S. Schreiber, P. Rosenstiel, F. Faltraco, 2009, Pharmacogenomics.

MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression

I. Cascorbi, E. Turrini, S. Haenisch, 2012, Pharmacogenetics and genomics.

Intestinal expression of P‐glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate–glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans

H. Kroemer, W. Weitschies, I. Cascorbi, 2006, Clinical pharmacology and therapeutics.

Analysis of alternative promoter usage in expression of HSD11B1 including the development of a transcript-specific quantitative real-time PCR method.

I. Cascorbi, E. Maser, C. A. Staab, 2011, Chemico-biological interactions.

CYP3A5 Genotype Markedly Influences the Pharmacokinetics of Tacrolimus and Sirolimus in Kidney Transplant Recipients

U. Kunzendorf, A. Caliebe, I. Cascorbi, 2007, Clinical pharmacology and therapeutics.

Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy.

I. Cascorbi, M. Ufer, S. Haenisch, 2010, Basic & clinical pharmacology & toxicology.

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

I. Cascorbi, W. Siegmund, S. Haenisch, 2006, British journal of clinical pharmacology.

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

H. Kroemer, I. Cascorbi, S. Haenisch, 2007, The Pharmacogenomics Journal.

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy

U. Stephani, H. Muhle, I. Cascorbi, 2011, Pharmacogenetics and genomics.

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients

N. Barbaro, D. Lowenstein, K. Kaiboriboon, 2015, Neurobiology of Disease.

Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients

I. Cascorbi, C. Remmler, M. Ufer, 2011, European Journal of Clinical Pharmacology.

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

H. Kroemer, I. Cascorbi, S. Haenisch, 2007, The Pharmacogenomics Journal.

Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes.

F. Moosig, I. Cascorbi, S. Wieczorek, 2016, Pharmacogenomics.

Pharmacogenetics of ATP-binding cassette transporters and clinical implications.

I. Cascorbi, S. Haenisch, 2010, Methods in molecular biology.

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

A. Caliebe, I. Cascorbi, W. Siegmund, 2008, Pharmacogenetics and genomics.

VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION

H. Kroemer, I. Cascorbi, C. Fusch, 2005, Drug Metabolism and Disposition.

Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis.

Paul D. Martin, I. Cascorbi, C. Heidecke, 2019, Journal of pharmaceutical sciences.

Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance.

K. Drerup, I. Cascorbi, S. Haenisch, 2016, Pharmacogenomics.

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance

C. Pott, I. Cascorbi, S. Haenisch, 2020, Experimental Hematology & Oncology.

Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients

I. Cascorbi, C. Remmler, M. Ufer, 2012, European Journal of Clinical Pharmacology.

Genetic variants may play an important role in mRNA–miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379

I. Cascorbi, A. Werk, S. Haenisch, 2014, Pharmacogenetics and genomics.

Down-Regulation of ATP-Binding Cassette C2 Protein Expression in HepG2 Cells after Rifampicin Treatment Is Mediated by MicroRNA-379

I. Cascorbi, C. Remmler, A. Werk, 2011, Molecular Pharmacology.

Transient Receptor Potential Channel Polymorphisms Are Associated with the Somatosensory Function in Neuropathic Pain Patients

Ralf Baron, Roman Rolke, Walter Magerl, 2011, PloS one.

miRNAs as mediators of drug resistance.

I. Cascorbi, S. Haenisch, 2012, Epigenomics.

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

F. Faltraco, U. Stephani, R. Häsler, 2009, Pharmacogenetics and genomics.

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

O. Ammerpohl, I. Cascorbi, I. Nagel, 2017, Oncotarget.

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

I. Cascorbi, E. Turrini, W. Siegmund, 2011, The Pharmacogenomics Journal.

MicroRNAs and their relevance to ABC transporters.

I. Cascorbi, A. Werk, S. Haenisch, 2014, British journal of clinical pharmacology.

miRNA-187-3p-Mediated Regulation of the KCNK10/TREK-2 Potassium Channel in a Rat Epilepsy Model.

V. Waetzig, I. Cascorbi, H. Potschka, 2016, ACS chemical neuroscience.

Biodistribution and pharmacokinetics of the (99m)Tc labeled human elastase inhibitor, elafin, in rats.

U. Lützen, Marlies Marx, Yi Zhao, 2016, Drug Metabolism and Pharmacokinetics.

Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine.

Paul D. Martin, M. Ostrowski, I. Cascorbi, 2017, Molecular pharmaceutics.

Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.

F. Faltraco, I. Cascorbi, D. Thal, 2013, Pharmacogenomics.

SIGMA-1 Receptor Gene Variants Affect the Somatosensory Phenotype in Neuropathic Pain Patients.

R. Treede, R. Baron, J. Gierthmühlen, 2019, The journal of pain : official journal of the American Pain Society.

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients

N. Barbaro, D. Lowenstein, K. Kaiboriboon, 2015, Neurobiology of Disease.